文献速递慢性肾脏病肾血管病与高血压

子痫前期后慢性肾病的实验室征象

Laboratory Signs of CKD after Preeclampsia.
PubMed 文献 · J Am Soc Nephrol · 2026-01-02

瑞典斯德哥尔摩基于人群的队列研究,纳入171,693次妊娠,使用逆概率治疗加权。子痫前期与白蛋白尿>300 mg/g、eGFR<60 ml/min/1.73 m²及复合结局风险升高相关,但产后肾脏监测率低。

要点

  • 子痫前期史与白蛋白尿>300 mg/g风险升高相关(加权HR 2.53)。
  • 子痫前期史与eGFR<60 ml/min/1.73 m²风险升高相关(加权HR 2.18)。
  • 子痫前期女性产后第一年血肌酐或尿白蛋白检测率低(20%和10%)。

核心结论

  • 子痫前期与早期肾损伤的实验室征象风险升高相关。
  • 产后肾功能监测率低,限制了早期发现和干预的机会。

研究设计与样本

  • 基于瑞典斯德哥尔摩的人群队列研究,使用逆概率治疗加权减少混杂。
  • 共纳入171,693次妊娠(170,192名女性,平均年龄29岁,标准差5),其中10,538次(6%)至少一次妊娠并发子痫前期。

主要发现

  • 中位随访7.0年(四分位距3.3-10.5),白蛋白尿>300 mg/g发生775次妊娠(0.5%),eGFR<60 ml/min/1.73 m²发生248次妊娠(0.1%),复合结局发生985次妊娠(0.6%)。
  • 每1000人年发病率:子痫前期 vs 无子痫前期,白蛋白尿>300 mg/g为1.53 vs 0.57,eGFR<60 ml/min/1.73 m²为0.52 vs 0.18,复合结局为2.00 vs 0.73。
  • 加权风险比:白蛋白尿>300 mg/g为2.53(95%CI 2.04-3.13),eGFR<60 ml/min/1.73 m²为2.18(95%CI 1.49-3.19),复合结局为2.43(95%CI 2.01-2.95)。
  • 产后第一年,子痫前期女性中2080人(20%)检测血清肌酐,1043人(10%)检测尿白蛋白。

关键数值与推荐

  • 白蛋白尿定义:尿白蛋白-肌酐比值>300 mg/g。
  • eGFR<60 ml/min/1.73 m²。
  • 复合结局:白蛋白尿>300 mg/g和/或eGFR<60 ml/min/1.73 m²。

临床怎么用

  • 对子痫前期女性应加强产后肾功能监测,包括血清肌酐和尿白蛋白检测。
  • 子痫前期史可作为早期识别CKD高风险女性的依据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

KEY POINTS: Women with preeclampsia had a higher risk of incident albuminuria >300 mg/g, eGFR <60 ml/min per 1.73 m 2 , or the composite outcome. The higher risk extended across multiple outcomes, including CKD diagnoses and nephrology referrals. Despite these risks, postpartum monitoring of kidney function was infrequent, limiting opportunities for early detection and intervention. BACKGROUND: Preeclampsia, a systemic hypertensive disorder of pregnancy, has been associated with the risk of kidney failure, an outcome that may take decades to develop. However, its association with early kidney disease, which could be targeted for intervention, remains underexplored. Here, we quantified the risk of CKD, defined by laboratory markers of kidney damage, in women who had a pregnancy complicated by preeclampsia versus a pregnancy without preeclampsia. METHODS: This was a population-based cohort study in Stockholm, Sweden, using inverse probability of treatment weights to minimize confounding. All nulliparous women who had at least one pregnancy ending in live or stillbirth between January 1, 2006, and December 31, 2020, were identified, excluding preexisting hypertension, diabetes, or CKD. Primary outcomes were ( 1 ) albuminuria defined by urine albumin-creatinine ratio >300 mg/g, ( 2 ) eGFR <60 ml/min per 1.73 m 2 , and ( 3 ) composite of albuminuria >300 mg/g and/or eGFR <60 ml/min per 1.73 m 2 . RESULTS: The study included 171,693 pregnancies (170,192 women: mean [SD] age, 29 [5] years), of whom 10,538 (6%) had at least one pregnancy complicated by preeclampsia. During a median follow-up of 7.0 years (interquartile range, 3.3-10.5), albuminuria >300 mg/g occurred after 775 pregnancies (0.5%), eGFR <60 ml/min per 1.73 m 2 occurred after 248 pregnancies (0.1%), and the composite outcome occurred after 985 pregnancies (0.6%). Incidence rates per 1000 person-years were higher after preeclampsia versus no preeclampsia for albuminuria >300 mg/g (1.53 versus 0.57), eGFR <60 ml/min per 1.73 m 2 (0.52 versus 0.18), and the composite outcome (2.00 versus 0.73). Weighted hazard ratios were 2.53 (95% confidence interval [CI], 2.04 to 3.13) for albuminuria >300 mg/g, 2.18 (95% CI, 1.49 to 3.19) for eGFR <60 ml/min per 1.73 m 2 , and 2.43 (95% CI, 2.01 to 2.95) for the composite outcome. In the first postpartum year, 2080 (20%) and 1043 (10%) of women with preeclampsia had serum creatinine or urine albumin testing, respectively. CONCLUSIONS: Preeclampsia was associated with a higher risk of laboratory signs of early kidney damage. There were low rates of postpartum kidney function monitoring.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Yo JH, Yang Y, Caldinelli A, et al. Laboratory Signs of CKD after Preeclampsia. J Am Soc Nephrol. 2026. PMID: 41568873. doi:10.1681/ASN.0000001001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。